| __timestamp | Novo Nordisk A/S | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26760000000 | 49315000 |
| Thursday, January 1, 2015 | 32169000000 | 75043000 |
| Friday, January 1, 2016 | 32339000000 | 83749000 |
| Sunday, January 1, 2017 | 32124000000 | 122682000 |
| Monday, January 1, 2018 | 33313000000 | 207761000 |
| Tuesday, January 1, 2019 | 35830000000 | 284812000 |
| Wednesday, January 1, 2020 | 36886000000 | 317875000 |
| Friday, January 1, 2021 | 41058000000 | 282660000 |
| Saturday, January 1, 2022 | 50684000000 | 451421000 |
| Sunday, January 1, 2023 | 61598000000 | 481871000 |
| Monday, January 1, 2024 | 67377000000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Novo Nordisk A/S and Sarepta Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, Novo Nordisk has consistently maintained higher SG&A expenses, peaking at approximately $61.6 billion in 2023. This reflects their expansive global operations and robust marketing strategies. In contrast, Sarepta Therapeutics, with a focus on niche markets, has kept its SG&A costs significantly lower, reaching around $482 million in 2023.
Despite the disparity in absolute numbers, both companies have shown a steady increase in SG&A expenses over the years. Novo Nordisk's expenses grew by about 130% from 2014 to 2023, while Sarepta's increased by nearly 878%. This data highlights the different strategic approaches each company takes in managing operational costs.
Novo Nordisk A/S or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Novo Nordisk A/S vs ImmunityBio, Inc. Trends and Insights
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Vertex Pharmaceuticals Incorporated vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. or Halozyme Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends